MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1
- PMID: 31486477
- DOI: 10.26355/eurrev_201908_18717
MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1
Abstract
Objective: To explore whether microRNA-579-3P was involved in the development of osteoporosis, and to investigate the possible molecular mechanisms.
Patients and methods: The messenger RNA (mRNA) expression levels of microRNA-579-3P, alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2) and bone sialoprotein (BSP) in serum samples of osteoporosis patients and normal controls were detected by quantitative Real-time polymerase chain reaction (qRT-PCR), respectively. Meanwhile, the expressions of the above genes during osteogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs) were examined as well. To investigate the effect of microRNA-579-3P on osteogenesis, microRNA-579-3P was overexpressed and knocked down in hMSCs. Subsequently, the mRNA and protein expression levels of osteogenesis-related genes, such as ALP, RUNX2 and BSP, were detected by qRT-PCR and Western blot, respectively. In addition, ALP activity and mineralization forming ability were evaluated by ALP staining and alizarin red staining. Bioinformatics predicted that Sirt1 was the target gene of microRNA-579-3P. Subsequent luciferase reporter gene assay was performed to verify the binding relationship of microRNA-579-3P to Sirt1. Meanwhile, qRT-PCR and Western blot were used to detect the changes in the mRNA and protein expression levels of Sirt1, respectively. After overexpression of microRNA-579-3P and Sirt1, qRT-PCR, Western blot, ALP staining and alizarin red staining assays were performed to detect the osteogenic differentiation of hMSCs.
Results: The expression of microRNA-579-3P in serum of patients with osteoporosis was significantly higher than that of normal controls. Meanwhile, the expression of microRNA-579-3P decreased gradually during osteogenic differentiation of hMSCs. Overexpression of microRNA-579-3P significantly reduced the expressions of osteogenic related genes, including ALP, RUNX2 and BSP. Besides, ALP activity and mineralized nodule formation ability decreased obviously as well. Luciferase reporter gene assay showed that microRNA-579-3P could bind to Sirt1. After overexpression of microRNA-579-3P, the mRNA and protein expression levels of Sirt1 were significantly reduced, which were reversed after silence of microRNA-579-3P. Simultaneous overexpression of microRNA-579-3P and Sirt1 could reverse the inhibition of osteogenic differentiation of hMSCs caused by overexpression of microRNA-579-3P alone.
Conclusions: MicroRNA-579-3P could inhibit osteogenic differentiation of hMSCs by regulating Sirt1, thereby promoting the development of osteoporosis.
Similar articles
-
MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression.Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):1-10. doi: 10.26355/eurrev_202001_19889. Eur Rev Med Pharmacol Sci. 2020. PMID: 31957812
-
MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.Biochem Biophys Res Commun. 2019 Aug 27;516(3):666-672. doi: 10.1016/j.bbrc.2019.06.083. Epub 2019 Jun 24. Biochem Biophys Res Commun. 2019. PMID: 31248594
-
MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.Biomed Pharmacother. 2019 Aug;116:108960. doi: 10.1016/j.biopha.2019.108960. Epub 2019 May 18. Biomed Pharmacother. 2019. PMID: 31112871
-
SIRT1, a promising regulator of bone homeostasis.Life Sci. 2021 Mar 15;269:119041. doi: 10.1016/j.lfs.2021.119041. Epub 2021 Jan 13. Life Sci. 2021. PMID: 33453243 Review.
-
Bidirectional regulation of osteogenic differentiation by the FOXO subfamily of Forkhead transcription factors in mammalian MSCs.Cell Prolif. 2019 Mar;52(2):e12540. doi: 10.1111/cpr.12540. Epub 2018 Nov 5. Cell Prolif. 2019. PMID: 30397974 Free PMC article. Review.
Cited by
-
The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis.Int J Mol Sci. 2020 Jul 10;21(14):4886. doi: 10.3390/ijms21144886. Int J Mol Sci. 2020. PMID: 32664424 Free PMC article. Review.
-
Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures.Int J Mol Sci. 2021 May 15;22(10):5232. doi: 10.3390/ijms22105232. Int J Mol Sci. 2021. PMID: 34063380 Free PMC article.
-
The Role of MicroRNAs in Bone Metabolism and Disease.Int J Mol Sci. 2020 Aug 24;21(17):6081. doi: 10.3390/ijms21176081. Int J Mol Sci. 2020. PMID: 32846921 Free PMC article. Review.
-
The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities.Cancers (Basel). 2022 Apr 13;14(8):1963. doi: 10.3390/cancers14081963. Cancers (Basel). 2022. PMID: 35454868 Free PMC article. Review.
-
Osteoporosis pathogenesis and treatment: existing and emerging avenues.Cell Mol Biol Lett. 2022 Sep 4;27(1):72. doi: 10.1186/s11658-022-00371-3. Cell Mol Biol Lett. 2022. PMID: 36058940 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical